September 22, 2008 - GE Healthcare demonstrated a new diagnostic tool for heart failure called SyncTool by Syntermed on its GE Xeleris 2 workstations at the American Society of Nuclear Cardiology, Sept. 10-14, in Boston.

SyncTool software is designed to help to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT). SyncTool uses multiharmonic phase analysis (MHPA), a technology developed by Emory University medical scientists Ernest Garcia, Ph.D., and Ji Chen, Ph.D., and was licensed exclusively to Syntermed by Emory in June 2008. The software provides an automated analysis of LV function of conventional ECG-gated SPECT myocardial perfusion imaging.

Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed and the company will market ERTb software as ReconTools. ReconTools provide reconstructed data sets that can be analyzed by many quantitative platforms including Emory Cardiac Toolbox (ECTb), providing an integrated, complete software solution for myocardial perfusion SPECT imaging.

GE Healthcare is licensing SyncTool software as part of an Emory Cardiac Toolbox (ECTb) upgrade on all Xeleris 2 workstations. This software helps to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT).

Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed. The company will market ERTb software as ReconTools.

For more information: www.syntermed.com


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | PET Imaging

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
Subscribe Now